Roche’s Actemra wins approval for hospitalized Covid patients

Roche upgraded its emergency use authorization for Actemra in certain hospitalized Covid-19 patients to a full FDA approval, the company announced Wednesday, as cases climb in the US.

The approval comes roughly six months after the monoclonal antibody treatment received an EUA to treat hospitalized patients 2...

Click to view original post